SCHOTT and Primoceler Inc have entered into an acquisition agreement. The companies will join forces to advance the next generation of ultra-miniature, ultra-reliable medical implants. Primoceler’s “glass-only” laser micro bonding services can be completed without any heat or added materials. This creates new possibilities for the protection of sensitive electronics in medical implants, MEMS devices and other reliability-critical applications.
Primoceler Inc will remain in Tampere, Finland and all contact persons remain the same.
More information from this press release.